यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - inaktivēta inaktivētu vīrusu un baktēriju vakcīnas - cūkas - aktīvās imunizācijas cūkas no 3 nedēļu vecuma, pret cūku circovirus tips 2 (pcv2) samazināt vīrusu slodzi asins un limfoīdo audu un fekāliju atlaišanu, ko izraisa infekcija pcv2. aktīvai cūku imunizācijai, kas vecāka par 3 nedēļām, pret mycoplasma hyopneumoniae, lai samazinātu plaušu bojājumus, ko izraisa m. hyopneumoniae.

लातविया - लातवियाई - Pārtikas un veterinārais dienests, Zemkopības ministrija

orion corporation - tablete

लातविया - लातवियाई - Pārtikas un veterinārais dienests, Zemkopības ministrija

walmark,a.s. - tablete

लातविया - लातवियाई - Pārtikas un veterinārais dienests, Zemkopības ministrija

general nutrition corporation - kapsula

लातविया - लातवियाई - Pārtikas un veterinārais dienests, Zemkopības ministrija

general nutrition corporation - cits, kaplete

लातविया - लातवियाई - Pārtikas un veterinārais dienests, Zemkopības ministrija

helvetia direct marketing s.r.o. - tablete

लातविया - लातवियाई - Pārtikas un veterinārais dienests, Zemkopības ministrija

zao “gnc pm farma” - kapsula

यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunoloģiskie līdzekļi suidae - cūkas (nobarošanas) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

लातविया - लातवियाई - Pārtikas un veterinārais dienests, Zemkopības ministrija

herbamed ltd - pulveris

लातविया - लातवियाई - Ecolab

ecolab deutschland gmbh -